Creates "New Jersey Kratom Consumer Protection Act."
Impact
The proposed act has significant implications for state law regarding the marketing and sale of dietary supplements. By instituting explicit standards for kratom, including age restrictions preventing sales to individuals under 21, the law aims to mitigate health risks associated with kratom products. Retailers found in violation of these provisions may face serious penalties, including fines and potential imprisonment for severe breaches, thereby ensuring compliance with the act’s stipulations.
Summary
Senate Bill S3549, known formally as the 'New Jersey Kratom Consumer Protection Act', seeks to regulate the distribution, sale, and labeling of kratom products within the state. Recognizing kratom's stimulant and opioid-like properties, the act establishes comprehensive definitions and criteria for kratom retailers, while emphasizing the need for consumer protection. The legislation outlines specific rules regarding the safety and efficacy of kratom products intended for human consumption, mandating that retailers disclose essential information on product labels.
Contention
Notably, the bill’s provisions on labeling and product safety could stir debate among stakeholders in the nutritional supplement industry. Supporters argue that the act will bolster consumer safety by preventing harmful products from entering the market, while critics may express concerns about the feasibility of compliance and the potential economic impact on small retailers. As the bill moves through the legislative process, discussions regarding the effectiveness of the regulations and the implications for kratom use in the broader context of health and wellness are expected to intensify.
Controlled substances: other; sentencing guidelines for retail sale of products containing ephedrine or pseudoephedrine; modify. Amends sec. 13m, ch. XVII of 1927 PA 175 (MCL 777.13m). TIE BAR WITH: HB 4947'25